Kevin Lundquist joins us with 25 years in the financial industry, starting at Abbott Laboratories. He held various positions of increasing seniority at Caterpillar, Inc. culminating to the Chief Financial Officer for the Caterpillar Japan Division in Tokyo. He later joined Oracle and then Genentech/Roche where he was the Senior Director Finance, Global Drug Substance Manufacturing Operations. Mr. Lundquist has been the Vice President of Finance of Revance Therapeutics for the past two years.
Mr. Lundquist is a global and strategic financial executive within the pharmaceutical, medical device, heavy machinery, and technology sectors. He has managed FP&A activities, developed organizations, and driven strategic and tactical initiatives across organizations.
Current role